Drug delivery systems: An updated review - Wikidata - awgldk - TriplyDB

Drug delivery systems: An updated review

Drug delivery systems: An updated review

http://www.wikidata.org/entity/Q36300205

about

siRNA and RNAi optimization The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug delivery Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells Extracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapy Deformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery.Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.Poloxamer surfactant preserves cell viability during photoacoustic delivery of molecules into cells.Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance Investigation of Plasma Treatment on Micro-Injection Moulded Microneedle for Drug Delivery.Measuring Local Viscosities near Plasma Membranes of Living Cells with Photonic Force Microscopy.Linear and Non-Linear Optical Imaging of Cancer Cells with Silicon Nanoparticles Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.Oxyma-based phosphates for racemization-free peptide segment couplings Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats "A novel highly stable and injectable hydrogel based on a conformationally restricted ultrashort peptide"Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.Depicting Binding-Mediated Translocation of HIV-1 Tat Peptides in Living Cells with Nanoscale Pens of Tat-Conjugated Quantum Dots.Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro.Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity.Strategies for enhanced peptide and protein delivery.Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.Therapeutic potential of nanocarrier for overcoming to P-glycoprotein.Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine Molecular imprinted polymers as drug delivery vehicles.Management of retinoblastoma: opportunities and challenges.Application of Metal-Organic Framework Nano-MIL-100(Fe) for Sustainable Release of Doxycycline and Tetracycline.Coaxial electrospun fibers: applications in drug delivery and tissue engineering.Antibody Engineering for Pursuing a Healthier Future Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreatic cancer cells and adenocarcinoma human lung alveolar basal epithelial cells.Coumarin-containing-star-shaped 4-arm-polyethylene glycol: targeted fluorescent organic nanoparticles for dual treatment of photodynamic therapy and chemotherapy.Glutathione and glutathione derivatives in immunotherapy.Delivery of enteric neural progenitors with 5-HT4 agonist-loaded nanoparticles and thermosensitive hydrogel enhances cell proliferation and differentiation following transplantation in vivo.Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs.Liposome-targeted delivery for highly potent drugs.Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.Development and evaluation of anti-malarial bio-conjugates: artesunate-loaded nanoerythrosomes.Newer drug delivery systems in anesthesia.

P2860

Q26769738-55539822-B3D4-4D19-B369-11C1C6E190D6 Q26827175-DAF7B742-B6EF-4234-8D38-DD088A5B48B5 Q28076905-17F7FD8A-5E06-4474-81BA-9FE579C7739E Q28816971-A7AB1628-2C61-4CC0-ADB0-8A8CF306F618 Q28829328-B416CD5C-55D0-4AD3-9FE1-4A33708AFCB6 Q30357070-6688235B-47E4-4823-AB64-9905B4A4E45F Q30851553-F885C124-4B50-41EF-8715-9EF9B9FD416B Q33584148-66365093-8ABE-4EF7-A22F-0591C63C2159 Q33907380-E6FFB3EE-57B2-48B9-8F58-FB09212C9E15 Q35237140-C36E5571-4631-455B-998E-C3E1BEF1BC5E Q35550112-4845CFB9-FD91-4BDF-A902-00D0FCF3E208 Q35830407-AA0418F5-20B8-42C1-AEB9-ECA2E65CB376 Q36043850-D2F38F93-F557-4E53-8D1E-384B69CE6B35 Q36132223-8C3DF91B-C484-4A5F-B3CE-9B12E9125D53 Q36592213-078BB59B-B2FB-4EF4-B8E7-E27B0E078B63 Q36765036-16D319AB-7169-4E46-B6A4-83447D16E7B8 Q37070584-4D11D391-3714-4996-ABEC-7FF851941C90 Q37163331-74D80EE2-E086-4600-B88F-4C4F603FB0D8 Q37634520-8D5CE38C-C225-4BAC-B325-E1C3B9E2107E Q37679342-A793CA11-7CEE-46D7-97F6-7B036E58942A Q37701123-296593D6-7AF6-4295-9443-E469362AD03D Q37712921-F9A5301B-6AC3-4E0A-B8B3-E0929B2F1989 Q38104408-D0EDCA94-84DD-4352-98C7-0DC79613953F Q38233071-368CC61C-01DF-4C1B-86C3-FF19D2B22B01 Q38237724-9AA9ECA4-F4E2-4EEB-AE0F-24DE2FC81EAC Q38245647-A0993C48-D943-40DA-8F84-0D745311FEAA Q38260438-878DF36F-BAE4-406C-893B-F660540797EF Q38372956-2768310D-FC61-410A-9158-00CD86316318 Q38637239-95AD76AA-BB31-4597-8FBC-3096195C5A3B Q38723841-BD3BB038-7B99-4B02-AB00-200480F196E3 Q38731632-044BB58B-70B0-421E-9482-EA51E4F6D9CC Q38777504-6BC0D493-C5E8-46FD-947C-3B644E378CFB Q38864976-A8D1D3E9-2B67-4F17-BCE9-844B4BCF82FF Q38924792-0A70FCD6-DDBB-4A90-A89C-6DC550CEB594 Q39017787-04EF4D54-79FF-47ED-99A1-0511C9EB46D0 Q39145487-66AB9BDC-3B26-4869-A1DE-C0DE8B3F5D9C Q39171223-48D49577-DB29-43AF-B7DC-D81B70B22BA0 Q39346006-2C64838E-991B-4B4C-BD10-253948D7A49F Q40681213-A121BD92-E4C2-474C-95CD-7568AC1BE620 Q41081606-52278EDA-5247-48F0-B15C-C3C79E862E8A

P2860

Drug delivery systems: An updated review

http://www.wikidata.org/entity/Q36300205

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Drug delivery systems: An updated review

@ast

Drug delivery systems: An updated review

@en

type

label

Drug delivery systems: An updated review

@ast

Drug delivery systems: An updated review

@en

prefLabel

Drug delivery systems: An updated review

@ast

Drug delivery systems: An updated review

@en

P1433

Q36300205-9E34E3D8-3A1E-4749-9D0B-272332702DA5

P1476

Q36300205-00B49B8F-7151-41E2-95AD-9E1EED9327E9

P2093

Q36300205-0F78D2C1-1260-433B-8A59-12F1073F1659

Q36300205-20CA79DD-8889-489C-9F5E-88F4BFE012FC

Q36300205-395FDD0A-74F5-48B0-8BAC-0DA0BFDD5E27

Q36300205-C4CA3B47-1B4C-41E4-AC54-8EA0B820A72E

Q36300205-DB92D0B2-5B07-4887-B5F8-73F8E5E88C73

Q36300205-DD0A0AD1-0251-4B4D-9DE2-70836B7973C4

Q36300205-F53E0993-22D7-4E64-8D7E-AD08C2992368

P2860

Q36300205-013F9E37-986C-45E1-9542-57B5C560806E

Q36300205-0B34898D-C9E5-4ADF-A248-EA42C557A789

Q36300205-0CDC4974-F438-4728-90F5-5D42DE2EB749

Q36300205-10969B09-BE29-4B9F-A049-7DD7EFA9E4DB

Q36300205-1D9AB770-7F69-48A4-8607-94C702E4D96A

Q36300205-1F78F0E3-18F7-4AF1-B4D8-4FCB63A08472

Q36300205-24E0E8A8-D94E-4714-A768-2E0E2EF3DAC7

Q36300205-286E4C57-20DB-4CBD-A764-51AFFD40DDEE

Q36300205-2D4B4915-3949-4F22-8BFF-400BCB5E13B6

Q36300205-322B0E63-7BE1-4AC1-A175-36090550EDDE

P304

Q36300205-A3F36FFA-F5D9-4809-8B76-36DB674BCD99

P31

Q36300205-88606BE6-4291-4FD0-8070-0827C0FD1F71

P356

Q36300205-C07F46F4-E9E9-4788-AA80-432A4687F1AF

P433

Q36300205-D886FA40-C148-4693-B839-D396451EE5DB

P478

Q36300205-E71D5B36-9974-4B06-8280-1286B574775B

P577

Q36300205-1B24DD96-560F-45FA-A4B1-F4214977AE66

P698

Q36300205-B297B17C-D022-4DA1-AE19-62BF85BAA3EC

P921

Q36300205-31A33FAF-B11B-434C-BB12-010AAFCDE798

P932

Q36300205-D83D8AC6-F8F5-404F-B800-D05AE3AA5596

P356

2230-973X.96920

P1433

International journal of pharmaceutical investigation

P1476

Drug delivery systems: An updated review

@en

P2093

Birendra Sriwastawa

http://www.w3.org/2001/XMLSchema#string

Gaurav Tiwari

http://www.w3.org/2001/XMLSchema#string

L Bhati

http://www.w3.org/2001/XMLSchema#string

P Pandey

http://www.w3.org/2001/XMLSchema#string

Ruchi Tiwari

http://www.w3.org/2001/XMLSchema#string

S Pandey

http://www.w3.org/2001/XMLSchema#string

Saurabh K Bannerjee

http://www.w3.org/2001/XMLSchema#string

P2860

Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.

Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages

Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.

Biodegradable polymeric nanoparticles as drug delivery devices.

Trojan particles: large porous carriers of nanoparticles for drug delivery.

Long-circulating and target-specific nanoparticles: theory to practice.

Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.

Nanocapsule technology: a review.

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.

Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.

P304

2-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2230-973X.96920

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23071954

http://www.w3.org/2001/XMLSchema#string

P921

P932

3465154

http://www.w3.org/2001/XMLSchema#string